Literature DB >> 26105975

Association between nonalcoholic fatty liver disease and bone mineral density: a systematic review and meta-analysis.

S Upala1, A Sanguankeo, V Jaruvongvanich.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26105975     DOI： 10.1007/s40618-015-0342-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

Review 1.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

2.  Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density.

Authors:  Senay Arikan; Alpaslan Tuzcu; Mithat Bahceci; Sehmuz Ozmen; Deniz Gokalp
Journal:  J Clin Densitom       Date:  2012-02-09       Impact factor: 2.617

3.  Negative association between trunk fat, insulin resistance and skeleton in obese women.

Authors:  Emanuela A Greco; Davide Francomano; Rachele Fornari; Chiara Marocco; Carla Lubrano; Vincenza Papa; Francesca Wannenes; Luigi Di Luigi; Lorenzo M Donini; Andrea Lenzi; Antonio Aversa; Silvia Migliaccio
Journal:  World J Diabetes       Date:  2013-04-15
  3 in total
  4 in total

1.  Adipokines and bone metabolism: an interplay to untangle.

Authors:  J Pepe; C Cipriani; M Cilli; L Colangelo; S Minisola
Journal:  J Endocrinol Invest       Date:  2016-09-17       Impact factor: 4.256

2.  Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.

Authors:  S H Lee; J M Yun; S H Kim; Y G Seo; H Min; E Chung; Y S Bae; I S Ryou; B Cho
Journal:  J Endocrinol Invest       Date:  2016-08-25       Impact factor: 4.256

3.  Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.

Authors:  Belinda T Li; Tracey G Simon; Na Wang; Raymond T Chung; Kathleen E Corey; Laura E Dichtel; Elizabeth J Samelson; Douglas P Kiel; Michelle T Long
Journal:  Obesity (Silver Spring)       Date:  2021-02-02       Impact factor: 5.002

4.  Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease.

Authors:  Fangli Zhou; Yan Wang; Yujue Li; Mengjia Tang; Shan Wan; Haoming Tian; Xiang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-05       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.